Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...

書目詳細資料
Main Authors:	Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P
格式:	Journal article
語言:	English
出版:	2007

相似書籍

Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
由: Roelofs, A, et al.
出版: (2005)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
由: Croucher, P, et al.
出版: (2002)

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
由: Roelofs, A, et al.
出版: (2007)

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
由: Roelofs, A, et al.
出版: (2006)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
由: Croucher, P, et al.
出版: (2003)

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
由: Aronson, J, et al.
出版: (1990)

Pleiotropic effects of the HMG-CoA reductase inhibitors
由: Mihos CG, et al.
出版: (2011-04-01)

Regulation of HMG-CoA reductase activity in plants.
由: B A Stermer, et al.
出版: (1994-07-01)

Activation of HMG-CoA reductase by microsomal phosphatase
由: K R Feingold, et al.
出版: (1983-03-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
由: H J Harwood, Jr, et al.
出版: (1982-07-01)

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma
由: Mueller, G, et al.
出版: (2004)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
由: Mueller, G, et al.
出版: (2004)

Bisphosphonates--mechanisms of action in multiple myeloma.
由: Shipman, C, et al.
出版: (2000)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
由: Shipman, C, et al.
出版: (2000)

HMG CoA reductase of intestinal mucosa and liver of the rat
由: S. Shefer, et al.
出版: (1972-05-01)

Osteoprotegerin and the development of myeloma bone disease
由: Croucher, P, et al.
出版: (2004)

Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
由: JJ Hwa, et al.
出版: (1992-05-01)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
由: Marc M Schumacher, et al.
出版: (2015-03-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
由: Shipman, C, et al.
出版: (2001)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
由: Robert Ancuceanu, et al.
出版: (2024-10-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
由: Xuemei Li, et al.
出版: (2013-01-01)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
由: Kyung-Joo Kim, et al.
出版: (2023-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
由: Paolo Gelosa, et al.
出版: (2007-11-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
由: R Langdon, et al.
出版: (1977-01-01)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
由: DANIEL M. DUDA-SEIMAN, et al.
出版: (2011-01-01)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
由: H J Harwood, Jr, et al.
出版: (1984-09-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
由: Croucher, P, et al.
出版: (2001)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
由: Gene C. Ness, et al.
出版: (1998-01-01)

Mutations within the membrane domain of HMG-CoA reductase confer resistance to sterol-accelerated degradation
由: Peter C.W. Lee, et al.
出版: (2007-02-01)

Rapid reverse phase-HPLC assay of HMG-CoA reductase activity
由: Matteo Mozzicafreddo, et al.
出版: (2010-08-01)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
由: Sucharita Bose, et al.
出版: (2023-04-01)

Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
由: Hongwen Chen, et al.
出版: (2022-07-01)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in <i>Aspergillus fumigatus</i>?
由: Irene Gonzalez-Jimenez, et al.
出版: (2021-10-01)

Lepidopteran HMG-CoA reductase is a potential selective target for pest control
由: Yuan-mei Li, et al.
出版: (2017-01-01)

An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia
由: Diana S. Gesto, et al.
出版: (2020-08-01)

Effects of HMG-CoA Reductase Inhibitors (Statins) On Bone Mineral Density and Metabolism
由: Nehir Samancı, et al.
出版: (2004-06-01)

Molecular docking studies of Triphala with catalytic portion of HMG-CoA reductase enzyme
由: Prasoborn Rinthong, et al.
出版: (2023-04-01)

Influence of simvA glyzin on expression and inhibition of hmg-coa reductase in rats liver
由: Yu. I. Ragino, et al.
出版: (2015-06-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
由: Annisa Rizqi Dwi Oktaviani, et al.
出版: (2021-09-01)

HMG-CoA reductase III. Abstracts. June 4, 1983, San Francisco.
出版: (1983-10-01)